Nascent Biotech's total assets for Q1 2025 were $227.39K, a decrease of -58.81% from the previous quarter. NBIO total liabilities were $741.93K for the fiscal quarter, a -8.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.